397 related articles for article (PubMed ID: 17479860)
1. [The effect of statins on lipids peroxidation and activities of antioxidants enzymes in patients with dyslipidemia].
Broncel M; Koter-Michalak M; Chojnowska-Jezierska J
Przegl Lek; 2006; 63(9):738-42. PubMed ID: 17479860
[TBL] [Abstract][Full Text] [Related]
2. [Erythrocyte fluidity in patients with hyperlipidemia during statins therapy].
Broncel M; Chojnowska-Jezierska J; Koter-Michalak M; Franiak I
Pol Arch Med Wewn; 2005 Jun; 113(6):531-7. PubMed ID: 16454441
[TBL] [Abstract][Full Text] [Related]
3. [The anti-inflammatory and antioxidants effects of micronized fenofibrate in patients with visceral obesity and dyslipidemia].
Broncel M; Cieślak D; Koter-Michalak M; Duchnowicz P; Mackiewicz K; Chojnowska-Jezierska J
Pol Merkur Lekarski; 2006 May; 20(119):547-50. PubMed ID: 16875159
[TBL] [Abstract][Full Text] [Related]
4. Physicochemical modifications induced by statins therapy on human erythrocytes membranes.
Broncel M; Bała A; Koter-Michalak M; Duchnowicz P; Wojsznis W; Chojnowska-Jezierska J
Wiad Lek; 2007; 60(7-8):321-8. PubMed ID: 18175550
[TBL] [Abstract][Full Text] [Related]
5. Statins lower plasma and lymphocyte ubiquinol/ubiquinone without affecting other antioxidants and PUFA.
Passi S; Stancato A; Aleo E; Dmitrieva A; Littarru GP
Biofactors; 2003; 18(1-4):113-24. PubMed ID: 14695926
[TBL] [Abstract][Full Text] [Related]
6. Pitavastatin: novel effects on lipid parameters.
Chapman MJ
Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
[TBL] [Abstract][Full Text] [Related]
7. [The comparison of simvastatin and atorvastatin effects on hemostatic parameters in patients with hyperlipidemia type II].
Broncel M; Marczyk I; Chojnowska-Jezierska J; Michalska M; Sikora J; Kostka B
Pol Merkur Lekarski; 2005 Apr; 18(106):380-4. PubMed ID: 16161915
[TBL] [Abstract][Full Text] [Related]
8. Effects of simvastatin and pravastatin on peroxidation of erythrocyte plasma membrane lipids in patients with type 2 hypercholesterolemia.
Koter M; Franiak I; Broncel M; Chojnowska-Jezierska J
Can J Physiol Pharmacol; 2003 May; 81(5):485-92. PubMed ID: 12774855
[TBL] [Abstract][Full Text] [Related]
9. Similar effects of atorvastatin, simvastatin and pravastatin on thrombogenic and inflammatory parameters in patients with hypercholesterolemia.
Joukhadar C; Klein N; Prinz M; Schrolnberger C; Vukovich T; Wolzt M; Schmetterer L; Dorner GT
Thromb Haemost; 2001 Jan; 85(1):47-51. PubMed ID: 11204586
[TBL] [Abstract][Full Text] [Related]
10. Effects of pravastatin and atorvastatin on HDL cholesterol and glucose metabolism in patients with dyslipidemia and glucose intolerance: the PRAT study.
Sasaki J; Otonari T; Uchida Y; Ikeda Y; Biro S; Kono S;
J Atheroscler Thromb; 2013; 20(4):368-79. PubMed ID: 23257975
[TBL] [Abstract][Full Text] [Related]
11. Redox markers and inflammation are differentially affected by atorvastatin, pravastatin or simvastatin administered before endotoxin-induced acute lung injury.
Melo AC; Valença SS; Gitirana LB; Santos JC; Ribeiro ML; Machado MN; Magalhães CB; Zin WA; Porto LC
Int Immunopharmacol; 2013 Sep; 17(1):57-64. PubMed ID: 23747588
[TBL] [Abstract][Full Text] [Related]
12. The ability of statins to protect low density lipoprotein from oxidation in hypercholesterolemic patients.
Thallinger C; Urbauer E; Lackner E; Graselli U; Kostner K; Wolzt M; Joukhadar C
Int J Clin Pharmacol Ther; 2005 Dec; 43(12):551-7. PubMed ID: 16372516
[TBL] [Abstract][Full Text] [Related]
13. The effect of atorvastatin on erythrocyte membranes and serum lipids in patients with type-2 hypercholesterolemia.
Koter M; Broncel M; Chojnowska-Jezierska J; Klikczynska K; Franiak I
Eur J Clin Pharmacol; 2002 Nov; 58(8):501-6. PubMed ID: 12451426
[TBL] [Abstract][Full Text] [Related]
14. The effects of diazinon on lipid peroxidation and antioxidant enzymes in erythrocytes in vitro.
Altuntas I; Kilinc I; Orhan H; Demirel R; Koylu H; Delibas N
Hum Exp Toxicol; 2004 Jan; 23(1):9-13. PubMed ID: 15027810
[TBL] [Abstract][Full Text] [Related]
15. Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial.
Nicholls SJ; Brewer HB; Kastelein JJ; Krueger KA; Wang MD; Shao M; Hu B; McErlean E; Nissen SE
JAMA; 2011 Nov; 306(19):2099-109. PubMed ID: 22089718
[TBL] [Abstract][Full Text] [Related]
16. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
Strandberg TE; Feely J; Sigurdsson EL;
Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
[TBL] [Abstract][Full Text] [Related]
17. [Effects of atorvastatin, fluvastatin, pravastatin, and simvastatin on endothelial function, lipid peroxidation, and aortic atherosclerosis in hypercholesterolemic rabbits].
Jorge PA; Almeida EA; Ozaki MR; Jorge M; Carneiro A
Arq Bras Cardiol; 2005 Apr; 84(4):314-9. PubMed ID: 15880205
[TBL] [Abstract][Full Text] [Related]
18. Effects of switching statins on lipid and apolipoprotein ratios in the MERCURY I study.
Cheung RC; Morrell JM; Kallend D; Watkins C; Schuster H
Int J Cardiol; 2005 Apr; 100(2):309-16. PubMed ID: 15823640
[TBL] [Abstract][Full Text] [Related]
19. Effect of dietary n-3 and n-6 oils with and without food restriction on activity of antioxidant enzymes and lipid peroxidation in livers of cyclophosphamide treated autoimmune-prone NZB/W female mice.
Bhattacharya A; Lawrence RA; Krishnan A; Zaman K; Sun D; Fernandes G
J Am Coll Nutr; 2003 Oct; 22(5):388-99. PubMed ID: 14559931
[TBL] [Abstract][Full Text] [Related]
20. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
